Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation.

Br J Haematol 2008 Jun 18;141(6):827-39. Epub 2008 Apr 18.

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Chemotherapy resistance from imbalanced apoptosis regulation may contribute to poor outcome in leukaemias with t(4;11). Anti-apoptotic BCL-2 expression and target modulation were characterized in cell lines with t(4;11) and BCL-2 expression was examined in MLL and non-MLL infant/paediatric leukaemia cases by Western blot analysis and/or real-time polymerase chain reaction. Cytotoxicity of Genasensetrade mark (Oblimersen Sodium, G3139) alone or combined with cytotoxic drugs was assessed by MTT [(3-4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assays of the cell lines, applying pharmacostatistical response surface modelling of drug interactions. Apoptosis and cell cycle were evaluated by flow cytometry in RS4:11 cells. Primary leukaemias and cell lines with t(4;11) expressed abundant BCL2 mRNA and protein. Variable, sometimes substantial BCL2 mRNA was detected in other leukaemia subtypes. G3139 reduced BCL2 mRNA and protein in RS4:11 cells. The most sensitive cell line to single-agent G3139 was RS4:11. Low G3139 concentrations sensitized RS4:11 and MV4-11 cells to select anti-leukaemia cytotoxic drugs. In RS4:11 cells, combining G3139 with doxorubicin (ADR) increased active caspase 3 and TUNEL staining compared to ADR alone, indicating greater apoptosis, and G3139 increased S-phase progression. The abundant BCL-2 affords a molecular target in leukaemias with t(4;11). G3139 exhibits preclinical activity and synergy with select cytotoxic agents in RS4:11 and MV4-11 cells, and these effects occur through apoptosis.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.07100.xDOI Listing
June 2008
10 Reads

Publication Analysis

Top Keywords

leukaemias t411
12
cell lines
12
bcl2 mrna
12
rs411 cells
12
bcl-2 expression
8
lines t411
8
mrna protein
8
cytotoxic drugs
8
mv4-11 cells
8
rs411 mv4-11
8
molecular target
8
target leukaemias
8
anti-apoptotic bcl-2
8
g3139
7
rs411
6
cell
5
cells
5
t411
5
protein variable
4
t411 expressed
4

References

(Supplied by CrossRef)

Coustan-Smith E. et al.
Blood 1996

Felix C.A. et al.
Blood 1997

Gewirtz A.M. et al.
Blood 1998

Similar Publications